Our News on Newswise

Newswise: 665f31d8c4099_DavidWeinerlab.jjpg.jpg

Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer

Wistar scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in...
4-Jun-2024 11:05 AM EDT Add to Favorites

Newswise: 665618d906771_SSoldanPLieberman.jpg

Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy

Wistar Institute’s Paul M. Lieberman, Ph.D., and lab, have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also...
28-May-2024 1:05 PM EDT Add to Favorites

Newswise: 66439d0f68e37_KShudaMcGuireWistarTrainingLab.jpg

The Wistar Institute Awarded Second National Science Foundation Grant to Expand Award-winning STEM Training Program

Wistar was awarded a $649,971 grant from the National Science Foundation (NSF) to support the continued expansion of its award-winning Biomedical Technician Training (BTT) Pre-apprenticeship Program.
14-May-2024 1:05 PM EDT Add to Favorites

Newswise: 6634f8da40019_FilippoVegliaWistarInstitute.jpg

Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer

The Wistar Institute assistant professor Dr. Filippo Veglia has discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor can grow unimpeded by the body’s defenses.
3-May-2024 11:00 AM EDT Add to Favorites

Newswise: 6630e8d24ea54_WeinerPortrait5.jpg

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The...
1-May-2024 9:10 AM EDT Add to Favorites

Newswise: 6616923d4274b_MAbdelMohsen.jpg

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

Wistar's Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV.
10-Apr-2024 9:30 AM EDT Add to Favorites

Newswise: 65de0f4c2ce7b_MaxBergerHeadshot.jpg

The Wistar Institute Appoints Max Berger to its Board of Trustees

The Wistar Institute Appoints Max Berger to its Board of Trustees
27-Feb-2024 11:05 AM EST Add to Favorites

Newswise: 65d8bd93aaea4_367WistarDay5.jpg

Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging

Wistar Institute’s Dr. Mohamed Abdel-Mohsen has demonstrated a connection between viral damage to the gut and premature biological aging.
23-Feb-2024 10:05 AM EST Add to Favorites


See All News

Our YouTube Videos

About

As a nonprofit biomedical research institution, The Wistar Institute is committed to conducting basic research to benefit society and to training the next generation of scientists. Integrity in research is essential to expanding our knowledge of the basic biological processes fundamental to life. All faculty, staff, trainees, and students involved in research at The Wistar Institute are required to maintain the highest standards of ethical conduct in research and to adhere to the rules and regulations of federal agencies governing biomedical research. Faculty and senior research staff are expected to serve as mentors to trainees and students, teaching them the standards of ethical practice in research. Elements of integrity in research include intellectual honesty in conducting and reporting research, maintenance of accurate research records and results, proper allocation of credit among co-authors of studies, fairness in peer review, openness in communications and sharing of resources, transparency in potential conflicts of interest, humane care of animals in the conduct of research, and protection of human subjects in the conduct of research.

Contacts

Darien Sutton
Director, Media Relations, Communications & Marketing

dsutton@wistar.org

215-898-3988

Twitter

close
0.2967